Northwest Biotherapeutics reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Agenus USD -0.3 0.84 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Celldex Therapeutics USD -1.22 0.21 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Merck USD 2.04 0.54 Dec/2025
Northwest Biotherapeutics USD -0.01 0.01 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Plus Therapeutics USD -0.04 0 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025